Concepedia

Author

Carter M. Suryadevara

Duke Medical Center

Also Known As

C. M. Suryadevara, C.M. Suryadevara, Carter M Suryadevara, Carter M. Suryadevara, Carter M. Suryadevara (549819), Carter Suryadevara

91

Publications

1.5K

Citations

18

H-Index

47

Concepts

All Affiliations

Duke Medical CenterDuke UniversityDuke University HospitalMassachusetts General Hospital
CM

About

Carter M. Suryadevara is an author at Duke Medical Center specializing in medicine, immunotherapy, and neuro-oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

8

8

371

2

Cell Biology

2

2

137

3

Engineering

1

1

50

4

Public Health

1

1

24

5

Biomedical Engineering

1

1

50

Carter M. Suryadevara

×

16

Publications

1.1K

Citations

14

H-Index

YearCitations

EGFRvIII mCAR-Modified T-Cell Therapy Cures Mice with Established Intracerebral Glioma and Generates Host Immunity against Tumor-Antigen Loss

John H. Sampson, Bryan D. Choi, Luis Sánchez-Pérez,

Clinical Cancer Research

2013

285

EGFRvIII-Specific Chimeric Antigen Receptor T Cells Migrate to and Kill Tumor Deposits Infiltrating the Brain Parenchyma in an Invasive Xenograft Model of Glioblastoma

Hongsheng Miao, Bryan D. Choi, Carter M. Suryadevara,

PLoS ONE

2014

120

Intracerebral delivery of a third generation EGFRvIII-specific chimeric antigen receptor is efficacious against human glioma

Bryan D. Choi, Carter M. Suryadevara, Patrick C. Gedeon,

Journal of Clinical Neuroscience

2013

107

Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma

Elizabeth A. Reap, Carter M. Suryadevara, Kristen A. Batich,

Cancer Research

2017

105

Temozolomide lymphodepletion enhances CAR abundance and correlates with antitumor efficacy against established glioblastoma

Carter M. Suryadevara, Rupen Desai, Melissa L. Abel,

OncoImmunology

2018

100

Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase–mutant Glioma

Marissa Spino, Sylvia C. Kurz, Luis Chiriboga,

Clinical Cancer Research

2018

77

Preventing Lck Activation in CAR T Cells Confers Treg Resistance but Requires 4-1BB Signaling for Them to Persist and Treat Solid Tumors in Nonlymphodepleted Hosts

Carter M. Suryadevara, Rupen Desai, S. Harrison Farber,

Clinical Cancer Research

2018

66

A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma

Patrick C. Gedeon, Teilo Schaller, Satish K. Chitneni,

Clinical Cancer Research

2018

55

Hyaluronic acid based low viscosity hydrogel as a novel carrier for Convection Enhanced Delivery of CAR T cells

Ahmet Atik, Carter M. Suryadevara, Ryan M. Schweller,

Journal of Clinical Neuroscience

2018

50

Impact of Insurance Provider on Overall Costs in Failed Back Surgery Syndrome: A Cost Study of 122,827 Patients

Aladine A. Elsamadicy, S. Harrison Farber, Siyun Yang,

Neuromodulation Technology at the Neural Interface

2017

24

Page 1